Xepa Laboratories started operations in Singapore in 1967. In 1973, a joint venture was formed with Soul-Pattinson Laboratories Pty. Ltd of Australia. With this expansion, operations were relocated to Malacca and Xepa-Soul Pattinson (Malaysia) was born. Since then, the company has emerged as one of the leading producers of quality pharmaceuticals in the country.

Xepa-Soul Pattinson is a member of Apex Healthcare Berhad (AHB) which was listed on the Kuala Lumpur Stock Exchange in June 2000.


Xepa-Soul Pattinson currently produces more than 100 products. These comprise tablets, capsules, liquid preparations, creams, ointments and sterile eyedrops - the majority of which are ethical products covering a wide range of therapeutic groups.


The Xepa-Soul Pattinson quest for excellence in quality is reflected in the modern production facilities, monitoring and control systems and in the meticulous training of its employees. The manufacturing plant is built on a modular concept to high standards of GMP.


Design and formulation of new products are conceived and developed by Xepa-Soul Pattinson's R&D team which consists of qualified pharmacists, chemists and other scientists. Xepa-Soul Pattinson focuses its R&D activities on developing high-end ethical pharmaceutical products, innovative packaging, better dose delivery systems and efficient manufacturing processes.


Xepa-Soul Pattinson's quality strategy involves an efficient combination of technology and skilled personnel to produce quality products that meet customer requirements and government regulatory standards for safety, efficacy and quality. Xepa-Soul Pattinson is committed to organization-wide quality control and assurance processes from senior management right through to the line operators.


Xepa-Soul Pattinsons' team of medical representatives maintain close communications with medical and dental practitioners, pharmacists and health institutions to keep them informed of the latest products and medical developments. Strategically located depots throughout the country ensure ready access to supplies. Apart from Malaysia, Xepa-Soul Pattinson export its products to 16 countries in the Asia Pacific region, the Middle East and Africa.

1-5 Cheng Industrial Estate, 75250 Melaka
Tel: 606-335 1515 / Fax: 606-335 5829 / 1575
Website: www.xepasp.com


Copyright © 2019 The Malaysian Organisation of Pharmaceutical Industries. All Rights Reserved.
Powered by Netxtreme Onesolution Sdn Bhd